Gabapentin
Product Images NDC 33358-153

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 33358-153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxchange Co., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A line graph showing mean pain scores over an 8-week period comparing placebo and Gabapentin 3600 mg/day. The x-axis represents weeks with a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis measures mean pain scores from 0 to 10. Gabapentin consistently shows lower mean pain scores compared to placebo throughout the timeline.*

FDA Label Image

Figure2 (Figure2)

A line chart displaying mean pain score over seven weeks for three groups: placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks, including a 3-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Gabapentin groups show a greater decrease in pain scores compared to placebo over time.*

FDA Label Image

Figure3 (Figure3)

A bar graph comparing the percentage of responders at endpoint in two studies. The x-axis shows different groups: placebo (PBO), Gabapentin 3600 mg (GBP 3600) for Study 1 and placebo, Gabapentin 1800 mg (GBP 1800), Gabapentin 2400 mg (GBP 2400) for Study 2. The y-axis represents the percentage ranging from 0 to 50%. Percentages are indicated on each bar, with significant p-values noted above some bars.*

FDA Label Image

Figure4 (Figure4)

A scatter plot chart showing percentage difference on the y-axis and daily dose in mg on the x-axis. The chart compares three studies labeled as STUDY a, STUDY b, and STUDY c with varying data points at doses of 600 mg, 900 mg, 1200 mg, and 1800 mg. Points are marked with different shading and letters corresponding to each study group.*

FDA Label Image

Gabapentin (Gaba300)

Gabapentin 300mg capsules label by RxChange Co. The label shows a sample lot with 90 capsules per container. It states the product is Rx only and provides storage instructions to keep the capsules in a tight/light-resistant container at controlled room temperature (68 to 77°F). Manufacturer information lists Amneal Pharmaceuticals Co. Pvt. Ltd., Ahmedabad, India.*

FDA Label Image

Structuraeformula (Structureformula)

Chemical structure of gabapentin showing a cyclohexane ring attached to a carbon connected to amino (CH2NH2) and carboxyl (CH2CO2H) functional groups.*

FDA Label Image

Formulation (Gabapentin Capsules Usp 1)

An illustration showing the formula for calculating creatinine clearance (CLCr), which includes variables for age in years, weight in kilograms, serum creatinine in mg/dL, and an adjustment factor of 0.85 for female patients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.